FRIENDLY CORPORATION Logo

FRIENDLY CORPORATION

Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.

8209 | T

Overview

Corporate Details

ISIN(s):
JP3829200009
LEI:
Country:
Japan
Address:
大東市寺川3丁目12番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Friendly Corporation is a creative company that provides comprehensive digital solutions to address corporate and social challenges. The firm specializes in a range of services designed to support business growth, including website production focused on brand storytelling and marketing outcomes. Its core offerings also encompass social media (SNS) and marketing consulting, advertising agency services, full-service e-commerce business support, and end-to-end new business incubation. The company partners with clients throughout the entire business lifecycle, from initial idea generation and strategic planning to product development, market entry, and acceleration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 08:00
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-11-10 08:00
Interim Report
半期報告書-第72期(2025/04/01-2026/03/31)
Japanese 214.9 KB
2025-06-30 03:26
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-06-27 05:01
Governance Information
内部統制報告書-第71期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-27 05:00
Registration Form
有価証券報告書-第71期(2024/04/01-2025/03/31)
Japanese 760.7 KB
2025-06-27 05:00
Registration Form
確認書
Japanese 8.6 KB
2025-05-09 09:00
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-04-14 04:08
Board/Management Information
臨時報告書
Japanese 20.6 KB
2025-02-10 08:00
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2024-11-08 08:01
Regulatory News Service
臨時報告書
Japanese 18.2 KB
2024-11-08 08:00
Interim Report
確認書
Japanese 8.7 KB
2024-11-08 08:00
Interim Report
半期報告書-第51期(2024/04/01-2025/03/31)
Japanese 216.0 KB
2024-06-28 03:00
Regulatory News Service
訂正臨時報告書
Japanese 22.6 KB
2024-06-24 04:58
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB
2024-06-24 03:01
Regulatory News Service
臨時報告書
Japanese 18.1 KB

Automate Your Workflow. Get a real-time feed of all FRIENDLY CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FRIENDLY CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FRIENDLY CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.